<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND OBJECTIVES: The enzyme telomerase is re-activated in most <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> but its mechanism of regulation in oesophageal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> is unclear </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to determine the roles of human telomerase reverse transcriptase (hTERT) <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression and hTERT <z:chebi fb="2" ids="33699">mRNA</z:chebi> splicing in the regulation of telomerase enzyme activity in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Paired samples from oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (n=21) and adjacent macroscopically <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa, and paired samples from <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> (n=16) and adjacent cardia mucosa were obtained </plain></SENT>
<SENT sid="3" pm="."><plain>Telomerase activity was measured by the telomeric repeat amplification protocol assay </plain></SENT>
<SENT sid="4" pm="."><plain>hTERT <z:chebi fb="2" ids="33699">mRNA</z:chebi> was quantified using real-time reverse transcriptase polymerase chain reaction (RT-PCR) </plain></SENT>
<SENT sid="5" pm="."><plain>Splice variants within the hTERT reverse transcriptase domain (alpha, beta, alpha beta) were detected by RT-PCR </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: In oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, compared to adjacent mucosa, median telomerase activity increased significantly (from 5 to 229 total product generated (tpg), P=0.0002), but median hTERT <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels were not significantly different </plain></SENT>
<SENT sid="7" pm="."><plain>Similarly, median telomerase activity was significantly higher in oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> compared to <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> (229 vs 20 tpg, P=0.001), but hTERT <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels were not significantly different </plain></SENT>
<SENT sid="8" pm="."><plain>There was no significant difference in telomerase activity and hTERT <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels between <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and adjacent cardia </plain></SENT>
<SENT sid="9" pm="."><plain>The frequency of detection of <z:hpo ids='HP_0000001'>all</z:hpo> variants increased from cardia to <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> to oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (P&lt;0.05) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: A major increase in telomerase activity occurs after the <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> stage in oesophageal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Levels of hTERT <z:chebi fb="2" ids="33699">mRNA</z:chebi> and hTERT <z:chebi fb="2" ids="33699">mRNA</z:chebi> splicing patterns did not correlate with telomerase activity and do not appear to regulate enzyme activity </plain></SENT>
<SENT sid="12" pm="."><plain>In this <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, an important clinical diagnostic role for the transcripts of the telomerase gene is improbable </plain></SENT>
</text></document>